Statements (53)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:pharmaceuticals
|
| gptkbp:brand |
gptkb:Rasuvo
|
| gptkbp:class |
Antirheumatic
|
| gptkbp:clinical_trial |
Phase 3
|
| gptkbp:clinical_use |
Chronic inflammatory conditions
|
| gptkbp:contraindication |
Pregnancy
Blood disorders Liver disease |
| gptkbp:dosage_form |
Pre-filled syringe
|
| gptkbp:drug_interactions |
NSAIDs
Live vaccines Other immunosuppressants |
| gptkbp:effective_date |
2016-01-28
|
| gptkbp:financial_support |
Financial assistance programs
Educational resources available Available through manufacturer |
| gptkbp:formulation |
Injectable
|
| https://www.w3.org/2000/01/rdf-schema#label |
Rasuvo
|
| gptkbp:indication |
Psoriatic arthritis
Juvenile idiopathic arthritis |
| gptkbp:ingredients |
gptkb:Methotrexate
|
| gptkbp:label |
gptkb:Nant_Kwest,_Inc.
|
| gptkbp:manufacturer |
gptkb:Nant_Kwest,_Inc.
|
| gptkbp:market_position |
Approved
|
| gptkbp:mechanism_of_action |
Antimetabolite
|
| gptkbp:packaging |
Single-dose vial
|
| gptkbp:patient_population |
Adults
|
| gptkbp:pharmacokinetics |
Excreted in urine
Absorption varies Metabolized in liver |
| gptkbp:price |
Varies by region
|
| gptkbp:provides_guidance_on |
Recommended for certain patients
|
| gptkbp:requires |
Available online
|
| gptkbp:research |
Ongoing studies for efficacy
Studies on long-term effects Comparative studies with other DMARDs |
| gptkbp:route_of_administration |
Subcutaneous
|
| gptkbp:safety |
Monitor liver function
Avoid in active infections Monitor blood counts |
| gptkbp:service_frequency |
Weekly
|
| gptkbp:side_effect |
gptkb:Nausea
Fatigue Headache Infection risk Dermatological reactions Gastrointestinal toxicity Pulmonary toxicity |
| gptkbp:storage |
Refrigerated
|
| gptkbp:type_of_care |
Important for efficacy
|
| gptkbp:used_for |
Rheumatoid arthritis
|
| gptkbp:bfsParent |
gptkb:Rheumatrex
|
| gptkbp:bfsLayer |
6
|